EUVIMED · CrossrefJournal
Seminars in Hematology
ISSN 0037-1963 · Elsevier BV
Latest articles
Ribosome Profiling: A Functional Genomics Approach to Study Translation in Hematologic Disease
Outcomes and challenges of stem cell transplantation in patients with ribosomopathies
Shwachman–Diamond syndrome: A paradigm for ribosomopathies, somatic genetic rescue, and leukemia predisposition syndrome
Ribosome structure, function and dysfunction at the molecular level
Gene-targeted therapies in inherited bone marrow failure syndromes
Gene therapy for hemoglobinopathies
Hematopoietic Proteostasis Across the Lifespan: From Fetal Development to Bone Marrow Failure
Sickle cell disease-specific barriers to in vivo hematopoietic stem cell gene therapy
Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge
Ten years of clinical genetic therapies for sickle cell disease: Current and future directions
More disease-modifying therapies for sickle cell disease: Are small molecules and drug repurposing the way forward?
The paradox of HbSC disease—Not so benign after all
Cellular pathogenesis of HbSC disease
Pain in SCD—Many mechanisms and mysteries
The many facets of cardiopulmonary complications in sickle cell disease
Sickle Cell Disease: Expanding the Frontiers of Pathophysiology and Therapeutics
outside front cover, PMS 8883 metallic AND 4/C
Stem cell transplantation and gene therapy for telomere biology disorders: Historical perspective, current approaches, and emerging strategies
Bone marrow failure in telomere biology disorders: Current understanding and the emerging landscape of non-transplant therapies
Rare somatic manifestations of telomere biology disorders
Solid malignancies in telomere biology disorders
Diagnosis and management of hematologic malignancies in the context of telomere biology disorders
Telomere biology disorders as an example of rare disease advocacy
Diagnosis and management of telomere biology disorders in developing countries
Telomere biology disorders and hepatic disease
Telomeres biology disorders: the past, the present and the future
outside front cover, PMS 8883 metallic AND 4/C
Table of contents
MRD in multiple myeloma: From an early endpoint for accelerated approval to MRD driven treatment and clinical management
Emerging technologies for minimal residual disease detection in hematologic malignancies
EUVIMED